Keywords: novartis, oral, trileptal, solution, approved, eu, under
Novartis' oral Trileptal solution approved in EU
Article | 21 August 2001
Under the European Mutual Recognition Procedure, evaluation of Novartis'easy-to-swallow oral suspension formulation of Trileptal (oxcarbazepine) as a treatment for epilepsy ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
